Margetuximab price in 2025

Margetuximab is an innovative antibody drug that has emerged in the treatment of HER2-positive breast cancer in recent years. Its research and development idea is to address the problems of drug resistance and diminishing efficacy of traditional HER2-targeted therapies. Through the optimization of molecular structure, it can enhance the binding ability between antibodies and immune effector cells, thereby improving the efficiency of the immune system in clearing tumor cells. Clinically, margetuximab is often used in combination with chemotherapy drugs for adult patients with metastatic breast cancer who have received at least two anti-HER2 regimens. It provides new treatment possibilities, especially when other drugs have limited efficacy.

Currently, margituximab has an original drug on the market in China, but due to its short time on the market, it has not yet been included in the medical insurance catalog, so the price information is not completely transparent. According to overseas channels, the drug has been supplied in Europe, Japan and other places. The common specification is 250mg/10ml*1 bottle/box, and the price may be around 30,000 yuan. Since drugs are imported products, their prices will be affected by exchange rate fluctuations and local market policies, so the specific costs may vary. If domestic patients need medication, they usually need to obtain it through regular hospital pharmacies or designated channels. Do not purchase it through unknown channels to avoid affecting the safety and efficacy of medication. There are currently no generic versions of margetuximab on the market. This means that in the short term, patients can only choose original drugs, and the price pressure is relatively high.

In terms of application, margituximab is not a "universal antidote" that can replace all anti-HER2 drugs, but is more of an important choice in multi-line treatment. It can still be effective after receiving drugs such as trastuzumab, pertuzumab or T-DM1, which is of great significance for patients with long disease course and complicated treatment experience. Doctors will take into account the patient's previous medication history, tumor burden, and tolerance when prescribing to ensure the best therapeutic effect.

Reference materials:https://www.margenza.com/